Jubilant Generics receives show-cause notice demanding over Rs 105 cr
NewsAug 28, 2026
- Markets
- MasterclassNEW
- Portfolio X-rayNEW
- My Watchlist
- News
- Stock Recos
- Screeners
- ETMarkets GPTNEW
US StocksNEW
- Sector: Pharmaceuticals
- Industry: Pharma - Indian
Jubilant Life - Jubilant Pharmova Share Price
907.6025.71 (2.92%)
Volume: 3,13,483
ClosedLast Updated On: 01 Sep, 2026, 03:53 PM IST
- Open:882.00
- High:914.75
- Low:873.60
Loading...
Research insights
Stock Recommendations
Potential
Upside*1 Year
Target
BUY
Mean Recos by
4 Analysts
Stock Reports Plus
/10
Stock Score
View Report
| Earnings | |
| Fundamentals | |
| Relative Valuation | |
| Risk | |
| Price Momentum |
No Rating (NR)
Negative
Neutral
Positive
* Investments in securities are subject to market risks. These are indicative and should not be interpreted as investment advice or guaranteed returns.
Key Metrics
PE RatioThis is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. | 41.06 | ||||||||||
EPS - TTMEarnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters. | 22.11 | ||||||||||
MCapMCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. | 14,456.36 | ||||||||||
Sectoral MCap RankThis is the ranking of a company within its sector based on MCap or Market capitalization. Higher the market capitalization of a company, higher the rank it is assigned. | 43 | ||||||||||
PB RatioPrice to Book represents the ratio of current market price of a stock to its book value per share. The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time. | 1.98 | ||||||||||
Dividend YieldDividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. All other things being equal, higher the dividend yield of the stock, the better it is for investors. | 0.55 | ||||||||||
Face ValueFace value of a stock is the value ascribed to the stock as per the balance sheet of the company. The dividend declared by a company is usually declared as a percentage of face value. | 1.00 | ||||||||||
Beta
| 0.68 | ||||||||||
VWAPVolume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point. | 895.97 | ||||||||||
52W H/LThis represents the 52 week high and low price of the security. It is also the 1 year high and low of the security. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today. | 1,184.80 / 786.05 |
Jubilant Life Share Price Insights
- Company witnessed QoQ revenue decline of 2.78%, which is lowest in the last 3 years. (Source: Consolidated Financials)
- Company's annual revenue growth of 14.46% outperformed its 3 year CAGR of 9.61%. (Source: Consolidated Financials)
- Company has spent 2.56% of its operating revenues towards interest expenses and 32.62% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Jubilant Pharmova Ltd. share price moved up by 2.92% from its previous close of Rs 881.90. Jubilant Pharmova Ltd. stock last traded price is 907.60
Share Price Value Today/Current/Last 907.60 Previous Day 881.90
Jubilant Life Share Price Returns
| 1 Day | 2.92% |
| 1 Week | 1.22% |
| 1 Month | -2.95% |
| 3 Months | -8.1% |
| 1 Year | -12.84% |
| 3 Years | 93.17% |
| 5 Years | 38.17% |
ET Stock ScreenersTop Score Companies
Check whether Jubilant Life belongs to analysts' top-rated companies list?
View Stock ScreenersNews & Analysis
Jubilant Generics receives show-cause notice demanding over Rs 105 cr
Stocks in news: Reliance Industries, Bank of Baroda, Power Grid, NATCO Pharma and JSW Infra
NewsAug 24, 2026
Receipt Of Show Cause Notice By Jubilant Pharmova Limited - GST
Announcement under Regulation 30 (LODR)-Newspaper Publication
Share Recommendations
Recent Recos
Current
Mean Recos by 4 Analysts
BUY
Strong SellSellHoldBuyStrong Buy
Analyst Trends
| Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 3 |
| Hold | - | - | - | - |
| Sell | 1 | 1 | 1 | - |
| Strong Sell | - | - | - | - |
| # Analysts | 4 | 4 | 4 | 4 |
Financials
Insights
| | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 |
|---|---|---|---|---|---|
| Total Income | 2,249.30 | 2,313.70 | 2,143.00 | 1,976.20 | 1,912.70 |
| Total Income Growth (%) | -2.78 | 7.97 | 8.44 | 3.32 | -1.44 |
| Total Expenses | 2,108.70 | 2,081.20 | 1,993.40 | 1,735.60 | 1,709.20 |
| Total Expenses Growth (%) | 1.32 | 4.40 | 14.85 | 1.54 | 1.62 |
| EBIT | 140.60 | 232.50 | 149.60 | 240.60 | 203.50 |
| EBIT Growth (%) | -39.53 | 55.41 | -37.82 | 18.23 | -21.37 |
| Profit after Tax (PAT) | 56.50 | 119.40 | 55.90 | 120.30 | 102.90 |
| PAT Growth (%) | -52.68 | 113.60 | -53.53 | 16.91 | -33.01 |
| EBIT Margin (%) | 6.25 | 10.05 | 6.98 | 12.17 | 10.64 |
| Net Profit Margin (%) | 2.51 | 5.16 | 2.61 | 6.09 | 5.38 |
| Basic EPS () | 3.57 | 7.55 | 3.52 | 7.59 | 6.49 |
All figures in Rs Cr, unless mentioned otherwise
View DetailsShare Price Forecast
Get multiple analysts' prediction on Jubilant Life
- High, low, medium predictions for Price
- Upcoming predictions for Revenue
- Details about company earnings
Technicals
Peer Comparison
MF Ownership
371.77
Amount Invested (in Cr.)
1.2%
% of AUM
5.75
% Change (MoM basis)
275.61
Amount Invested (in Cr.)
0.808967%
% of AUM
0.00
% Change (MoM basis)
175.24
Amount Invested (in Cr.)
0.59861266%
% of AUM
0.00
% Change (MoM basis)
Corporate Actions
| Meeting Date | Announced on | Purpose | Details |
|---|---|---|---|
| Aug 26, 2026 | Aug 3, 2026 | AGM | General Meeting |
| Aug 19, 2026 | Jul 20, 2026 | POM | General Meeting |
| Aug 10, 2026 | Aug 5, 2026 | Board Meeting | Quarterly Results |
| Aug 7, 2026 | Aug 5, 2026 | Board Meeting | Quarterly Results |
| May 22, 2026 | Apr 24, 2026 | Board Meeting | Audited Results & Final Dividend |
| Feb 6, 2026 | Jan 22, 2026 | Board Meeting | Quarterly Results |
| Oct 31, 2025 | Oct 14, 2025 | Board Meeting | Quarterly Results |
| Aug 29, 2025 | Aug 6, 2025 | AGM | General Meeting |
| Jul 26, 2025 | Jun 25, 2025 | POM | General Meeting |
| Aug 30, 2024 | Aug 12, 2024 | AGM | General Meeting |
About Jubilant Life
Jubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 14,456.36 Crore) operating in Pharmaceuticals sector.
Jubilant Pharmova Ltd. key Products/Revenue Segments include Sale of services, Other Operating Revenue for the year ending 31-Mar-2026.
HB
Hari S Bhartia
Co-ChairmanSB
Shyam S Bhartia
ChairmanPB
Priyavrat Bhartia
Managing DirectorAB
Arjun Shanker Bhartia
Joint Managing DirectorIndustry
Key Indices Listed On
Nifty 500, BSE 500, BSE 250 SmallCap Index, + 17 more
Address
Bhartiagram,, Gajraula,, Amroha District, Uttar Pradesh, 244223
FAQs about Jubilant Life share
- 1. What's Jubilant Life share price today and what are Jubilant Life share returns ?As on 01 Sep, 2026, 03:53 PM IST Jubilant Life share price is up by 2.92% basis the previous closing price of Rs 882.65. Jubilant Life share price is Rs 907.60. Return Performance of Jubilant Life Shares: 1 Week: Jubilant Life share price moved up by 1.22%
- 2. What are the returns for Jubilant Life share?Return Performance of Jubilant Life Shares: 1 Week: Jubilant Life share price moved up by 1.22%
- 3. What's the market capitalization of Jubilant Life?Market Capitalization of Jubilant Life stock is Rs 14,456.36 Cr.
- 4. What is 52 week high/low of Jubilant Life share price?52 Week high of Jubilant Life share is Rs 1,184.80 while 52 week low is Rs 786.05
- 5. What is the PE & PB ratio of Jubilant Life?The PE ratio of Jubilant Life stands at 39.89, while the PB ratio is 1.96.
Trending in Markets
Top Gainers
Top Losers
Jubilant Life Quick Links
Equity Quick Links
More from Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.
